Genetic toxicity studies with genistein

Food and Chemical Toxicology

Volumn 44, Issue 1, 2006, Pages 42-55

  Michael McClain, R ^a   Wolz, Erich ^b   Davidovich, Alberto ^c   Bausch, Jochen ^b  

^a McClain Associates   (United States)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^c DSM NUTRITIONAL PRODUCTS   (United States)

Author keywords

Ames test; Clastogenicity; Genistein; Genotoxicity; Micronucleus test; Mouse lymphoma test; Mutagenicity; Phytoestrogen; Soy

Indexed keywords

GENISTEIN;

AMES TEST; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTOXICITY; LYMPHOMA; MALE; METABOLIC ACTIVATION; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; RAT; SALMONELLA TYPHIMURIUM;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; BONE MARROW CELLS; CELL LINE, TUMOR; FEMALE; GENISTEIN; LEUKEMIA L5178; MALE; MICE; MICE, INBRED STRAINS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS; RATS, WISTAR; SALMONELLA TYPHIMURIUM; THYMIDINE KINASE;

ANIMALIA; GLYCINE MAX; RATTUS NORVEGICUS; SALMONELLA TYPHIMURIUM;

EID: 28844455623     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.06.004     Document Type: Article

References (49)

1. Albertini, S., 1995. Mutagenicity evaluation of Ro 24-2076/000 in the Ames test (Study 173M95). Hoffmann-La Roche Ltd., Basle (CH). Research Report B-0165480.
2. S. Albertini, A.A. Chetelat, B. Miller, W. Muster, E. Pujadas, R. Strobel, and E. Gocke Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems Mutagenesis 10 1995 343 351
3. B.N. Ames, J. McCann, and E. Yamasaki Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test Mutation Research 31 1975 347 364
4. S. Barnes Phytoestrogens and osteoporosis: what is a safe dose British Journal Nutrition 89 Suppl. 1 2003 S101 S108
5. S. Barnes, J. Sfakianos, L. Coward, and M. Kirk Soy isoflavinoids in cancer prevention. Underlying biochemical and pharmacological issues Advances in Experimental Medicine and Biology 1996 87 100
6. R.M. Bartholomew, and D.S. Ryan Lack of mutagenicity of some phytoestrogens in the Salmonella/mammalian microsome assay Mutation Research 78 1980 317 321
7. G. Boos, and H. Stopper Genotoxicity of several clinically used topoisomerase II inhibitors Toxicology Letters 116 2000 7 16
8. Collaborative Study Group for the Micronucleus Test (CSGMT), 1995. Protocol recommended by the CSGMT/JEMS.MMS for the short-term mouse peripheral blood micronucleus test. Mutagenesis 10, 153-159.
9. A. Constantinou, K. Kiguchi, and E. Huberman Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein Cancer Research 50 1990 2618 2624
10. A. Constantinou, R. Mehta, C. Runyan, K. Rao, A. Vaughan, and R. Moon Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships Journal of Natural Products 58 1995 217 225
11. A.L. Di Virgilio, K. Iwami, W. Watjen, R. Kahl, and G.H. Degen Genotoxicity of the isoflavones genistein, daidzein and equol in V79 cells Toxicology Letters 151 2004 151 162
12. FDA Guidance for Industry, 2004. Recommended approaches to integration of genetic toxicology study results (draft guidance published November 2004).
13. L.R. Ferguson, and B.C. Baguley Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes Mutation Research 355 1996 91 101
14. M. Fukutake, M. Takahashi, K. Ishida, H. Kawamura, T. Sugimura, and K. Wakabayashi Quantification of genistein and genistin in soybeans and soybean products Food and Chemical Toxicology 34 1996 457 461
15. S. Goldwyn, A. Lazinsky, and H. Wei Promotion of health by soy isoflavones: efficacy, benefit and safety concerns Drug Metabolism and Drug Interactions 17 2000 261 289
16. R.S. Gupta, A. Bromke, D.W. Bryant, R. Gupta, B. Singh, and D.R. McCalla Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems Mutagenesis 2 1987 179 186
17. S.H. Kaufmann Cell death induced by topoisomerase targeted drugs: more questions than answers Biochimica et Biophysica Acta 1400 1998 195 211
18. Kirchner, S., 2000. Ro24-2076/000: mouse lymphoma cell mutation test (ML/TK) (213M00). Hoffmann-La Roche Ltd., Basle (CH). Regulatory Document RDR-1002913.
19. K. Kiguchi, A.I. Constantinou, and E. Huberman Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells Cancer Communications 2 1990 271 277
20. D.C. Knight, and J.A. Eden A review of the clinical effects of phytoestrogens Obstetrics and Gynecology 87 1994 897 904
21. S.E. Kulling, and M. Metzler Induction of micronuclei, DNA strand breaks and HPRT mutations in cultured Chinese hamster V79 cells by the phytoestrogen coumoestrol Food and Chemical Toxicology 35 1997 605 613
22. S.E. Kulling, B. Rosenberg, E. Jacobs, and M. Metzler The phytoestrogens coumoestrol and genistein induce structural chromosomal aberrations in cultured human peripheral blood lymphocytes Archives of Toxicology 73 1999 50 54
23. D.E. Levin, E. Yamasaki, and B.N. Ames A new Salmonella tester strain, TA97, for the detection of frameshift mutagens: a run of cytosines as mutational hot spot Mutation Research 94 1982 315 330
24. D.E. Levin, M. Hollstein, M.F. Christman, E.A. Schwiers, and B.N. Ames A new Salmonella tester strain (TA102) with A:T base pairs at the site of mutation detects oxidative mutagens Proceedings of the National Academy of Sciences USA 79 1982 7445 7449
25. A. Lynch, J. Harvey, M. Aylott, E. Nicholas, M. Burman, A. Siddiqui, S. Walker, and R. Rees Investigations into the concept of a threshold for topoisomerase inhibitor-induce clastogenicity Mutagenesis 18 4 2003 345 353
26. J. Markovits, C. Linassier, P. Fosse, J. Couprie, J. Pierre, A. Jacquemin-Sablon, J.M. Saucier, J.B. Le Pecq, and A.K. Larsen Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II Cancer Research 49 1989 5111 5117
27. D.M. Maron, and B.N. Ames Revised methods for the Salmonella mutagenicity test Mutation Research 113 1983 173 215
28. T. Matsushima, T. Sugimura, M. Nagao, T. Yahagi, A. Shirai, and M. Sawamura Factors modulating mutagenicity in microbial tests K.H. Norpoth R.C. Garner Short Term Tests for Detecting Carcinogens 1980 Springer-Verlag Berlin 273 285
29. R.J. Miksicek Estrogenic flavonoids: structural requirements for biological activity Proceedings of the Society of Experimental Biology and Medicine 208 1995 44 50
30. W. Miltyk, C.N. Craciunescu, L. Fischer, R.A. Jeffcoat, M.A. Koch, W. Lopaczynski, C. Mahoney, R.A. Jeffcoat, J. Crowell, J. Paglieri, and S.H. Zeisel Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, glycitein) in 20 patients with prostate cancer American Journal of Clinical Nutrition 77 2003 875 882
31. R.R. Misra, S.D. Hursting, S.N. Perkins, N. Sathyamoorthy, J.C. Mirsalis, E.S. Riccio, and J.A. Crowell Genotoxicity and carcinogenicity studies of soy isoflavones International Journal of Toxicology 21 2002 277 285
32. S.M. Morris, J.J. Chen, O.E. Domon, L.J. McGarrity, M.E. Bishop, M.G. Manjanatha, and D.A. Casciano p53, mutations, and apoptosis in genistein-exposed human lymphoblastoid cells Mutation Research 405 1998 41 56
33. M.S. Morton, O. Arisaka, N. Miyake, L.D. Morgan, and B.A. Evans Phytoestrogen concentrations in serum from Japanese men and women over forty years of age Journal of Nutrition 132 2002 3168 3171
34. Muster, W., 1999. Ro 24-2076/000: micronucleus test (MNT) in peripheral blood of MORO mice after repeated oral administration (gavage). (Study 138M96). Hoffmann-La Roche Ltd., Basle (CH). Research report B-0165527.
35. Muster, W., 2004. Ro 24-2076-000 (Ro 24-2076/000 genistein): micronucleus test (MNT) in RAIf rat bone marrow after oral administration (gavage). (Study 960801). Hoffmann-La Roche Ltd., Basle (CH). RDR-1014218.
36. M. Nagao, N. Morita, T. Yahagi, M. Shimizu, M. Kuroyanagi, M. Fukuoka, K. Yoshihira, S. Natori, T. Fujino, and T. Sugimura Mutagenicity of 61 flavonoids and 11 related compounds Environmental Mutagenesis 3 1981 401 419
37. OECD, 1984. Guideline for testing of chemicals No. 476. Genetic toxicology: in vitro mammalian cell gene mutation tests, April 4, 1984. Organization for Economic Co-operation and Development, Paris.
38. OECD, 1987. Guideline for testing of chemicals No. 474-"Genetic toxicology: Micronucleus Test".
39. K. Polkowski, and A.P. Mazurek Biological properties of genistein. A review of in vitro and in vivo data Acta Polonaie Pharmaceutica 57 2000 135 155
40. I.R. Record, M. Jannes, I.E. Dreosti, and R.A. King Induction of micronucleus formation in mouse splenocytes by the soy isoflavone genistein in vitro but not in vivo Food and Chemical Toxicology 33 1995 919 922
41. C.R. Sirtori Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis Drug Safety 24 2001 665 682
42. R.D. Snyder, and P.J. Gillies Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids Food and Chemical Toxicology 41 2003 1291 1298
43. A.C. Suthar, M.M. Banavalikar, and M.K. Biyani Pharmacological activities of genistein, an isoflavone from soy (Glysine max): Part I-Anti-cancer activity Indian Journal of Experimental Biology 39 2001 511 519
44. A.C. Suthar, M.M. Banavalikar, and M.K. Biyani Pharmacological activities of genistein, an isoflavone from soy (Glysine max): Part II-Anti-cholesterol activity, effects on osteoporosis and menopausal symptoms Indian Journal of Experimental Biology 39 2001 520 525
45. T. Tsutsui, Y. Tamura, E. Yagi, H. Someya, I. Hori, M. Metzler, and J.C. Barrett Cell transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells International Journal of Cancer 105 2003 312 320
46. S. Withoff, S. De Jong, E.G. De Vries, and N.H. Mulder Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review) Anticancer Research 16 1996 1867 1880
47. Wolz, E., Damme, B., Chetelat, A., Matthes, B., Flade, D., 2004. Ro 24-2076/000 (genistein): micronucleus assay in bone marrow cells of the rat after oral administration (gavage). (Study 852991). Hoffmann-La Roche Ltd., Basle (CH). RDR-1015779.
48. T. Yahagi, M. Degawa, Y. Seino, T. Matsushima, and M. Nagao Mutagenicity of carcinogenic azo dyes and their derivatives Cancer Letters 1 1975 91 96
49. S. Yamamoto, T. Sobue, S. Sasaki, M. Kobayashi, Y. Arai, M. Uehara, H. Adlercreutz, S. Watanabe, T. Takahashi, Y. Litoi, Y. Iwase, M. Akabane, and S. Tsugane Validity and reproducibility of a self-administered food frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records in blood and urine isoflavones Journal of Nutrition 131 2001 2741 2747